RLYB CIK: 1739410

Rallybio Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
181
FY22:
179
FY23:
115
FY24:
67.8
FY25:
61.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.32
FY22:
0.94
FY23:
0.83
FY24:
0.27
FY25:
1.01
Total assets
Change from FY21 to FY25
millions USD
FY21:
182
FY22:
180
FY23:
116
FY24:
68.1
FY25:
62.3

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
6.55
FY22:
10.7
FY23:
9.26
FY24:
6.24
FY25:
4.22
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.03
FY22:
0.37
FY23:
0.17
FY24:
0.21
FY25:
0.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
176
FY22:
169
FY23:
106
FY24:
61.7
FY25:
58.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
182
FY22:
180
FY23:
116
FY24:
68.1
FY25:
62.3

All amounts in millions USD Data source:SEC EDGAR